Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins. / Chen, Fang; Tzarum, Netanel; Lin, Xiaohe; Giang, Erick; Velázquez-Moctezuma, Rodrigo; Augestad, Elias H.; Nagy, Kenna; He, Linling; Hernandez, Mayda; Fouch, Mallorie E.; Grinyó, Ariadna; Chavez, Deborah; Doranz, Benjamin J.; Prentoe, Jannick; Stanfield, Robyn L.; Lanford, Robert; Bukh, Jens; Wilson, Ian A.; Zhu, Jiang; Law, Mansun.
In: Immunity, Vol. 54, No. 4, 2021, p. 781-796.e4.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
AU - Chen, Fang
AU - Tzarum, Netanel
AU - Lin, Xiaohe
AU - Giang, Erick
AU - Velázquez-Moctezuma, Rodrigo
AU - Augestad, Elias H.
AU - Nagy, Kenna
AU - He, Linling
AU - Hernandez, Mayda
AU - Fouch, Mallorie E.
AU - Grinyó, Ariadna
AU - Chavez, Deborah
AU - Doranz, Benjamin J.
AU - Prentoe, Jannick
AU - Stanfield, Robyn L.
AU - Lanford, Robert
AU - Bukh, Jens
AU - Wilson, Ian A.
AU - Zhu, Jiang
AU - Law, Mansun
PY - 2021
Y1 - 2021
N2 - Human IGHV1-69-encoded broadly neutralizing antibodies (bnAbs) that target the hepatitis C virus (HCV) envelope glycoprotein (Env) E2 are important for protection against HCV infection. An IGHV1-69 ortholog gene, VH1.36, is preferentially used for bnAbs isolated from HCV Env-immunized rhesus macaques (RMs). Here, we studied the genetic, structural, and functional properties of VH1.36-encoded bnAbs generated by vaccination, in comparison to IGHV1-69-encoded bnAbs from HCV patients. Global B cell repertoire analysis confirmed the expansion of VH1.36-derived B cells in immunized animals. Most E2-specific, VH1.36-encoded antibodies cross-neutralized HCV. Crystal structures of two RM bnAbs with E2 revealed that the RM bnAbs engaged conserved E2 epitopes using similar molecular features as human bnAbs but with a different binding mode. Longitudinal analyses of the RM antibody repertoire responses during immunization indicated rapid lineage development of VH1.36-encoded bnAbs with limited somatic hypermutation. Our findings suggest functional convergence of a germline-encoded bnAb response to HCV Env with implications for vaccination in humans.
AB - Human IGHV1-69-encoded broadly neutralizing antibodies (bnAbs) that target the hepatitis C virus (HCV) envelope glycoprotein (Env) E2 are important for protection against HCV infection. An IGHV1-69 ortholog gene, VH1.36, is preferentially used for bnAbs isolated from HCV Env-immunized rhesus macaques (RMs). Here, we studied the genetic, structural, and functional properties of VH1.36-encoded bnAbs generated by vaccination, in comparison to IGHV1-69-encoded bnAbs from HCV patients. Global B cell repertoire analysis confirmed the expansion of VH1.36-derived B cells in immunized animals. Most E2-specific, VH1.36-encoded antibodies cross-neutralized HCV. Crystal structures of two RM bnAbs with E2 revealed that the RM bnAbs engaged conserved E2 epitopes using similar molecular features as human bnAbs but with a different binding mode. Longitudinal analyses of the RM antibody repertoire responses during immunization indicated rapid lineage development of VH1.36-encoded bnAbs with limited somatic hypermutation. Our findings suggest functional convergence of a germline-encoded bnAb response to HCV Env with implications for vaccination in humans.
KW - antibody germline
KW - broadly neutralizing antibody
KW - E1E2
KW - E2
KW - Hepatitis C virus
KW - IGHV1-69
KW - immunization
KW - vaccination
KW - VH1-69
KW - VH1.36
U2 - 10.1016/j.immuni.2021.02.013
DO - 10.1016/j.immuni.2021.02.013
M3 - Journal article
C2 - 33675683
AN - SCOPUS:85104157231
VL - 54
SP - 781-796.e4
JO - Immunity
JF - Immunity
SN - 1074-7613
IS - 4
ER -
ID: 260546954